Not available
Quote | KemPharm Inc (NASDAQ:KMPH)
Last: | $5.81 |
---|---|
Change Percent: | 0.0% |
Open: | $5.83 |
Close: | $5.81 |
High: | $5.97 |
Low: | $5.78 |
Volume: | 64,126 |
Last Trade Date Time: | 02/28/2023 03:00:00 am |
News | KemPharm Inc (NASDAQ:KMPH)
CELEBRATION, Fla., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: KMPH) (“Zevra” or the “Company” and formerly KemPharm, Inc.), a rare disease therapeutics company, today announced that it has become a Corporate Council member of the National Org...
CELEBRATION, Fla., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: KMPH) (“Zevra” or the “Company” and formerly known as KemPharm, Inc.), today announced it has filed its preliminary proxy statement with the U.S. Securities and Exchange Commission...
Message Board Posts | KemPharm Inc (NASDAQ:KMPH)
Subject | By | Source | When |
---|---|---|---|
OoooGAAAaaBoooGA! You buy more KemPharm Inc., shares! | gi197845 | investorshub | 11/16/2022 3:34:34 AM |
Uh oh doebop, it doesn't look good for | gi197845 | investorshub | 08/12/2022 1:46:16 AM |
I meant; | gi197845 | investorshub | 08/02/2022 9:48:26 PM |
Are you experiencing diarrhea do to the stress? | gi197845 | investorshub | 08/02/2022 9:04:23 PM |
Well. It at once but within short span | bhulkupk | investorshub | 07/26/2022 12:33:15 PM |
News, Short Squeeze, Breakout and More Instantly...
CELEBRATION, Fla., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: KMPH) (“Zevra” or the “Company” and formerly KemPharm, Inc.), a rare disease therapeutics company, today announced that it has become a Corporate Council member of the National Org...
CELEBRATION, Fla., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: KMPH) (“Zevra” or the “Company” and formerly known as KemPharm, Inc.), today announced it has filed its preliminary proxy statement with the U.S. Securities and Exchange Commission...
CELEBRATION, Fla., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: KMPH) (Zevra, or the Company, formerly KemPharm, Inc.), a rare disease therapeutics company, has announced that the Company will host a conference call and live audio webcast on Tuesday, March 7, 2023, at 8:3...